Internationalisation

 

Hillhouse and EQT vie to acquire global BPO provider GeBBS

The sale of US-based healthcare BPO firm GeBBS Healthcare Solutions has entered its final stage, with Asian and European funds competing for acquisition. Hong Kong’s Hillhouse Investment has emerged as the frontrunner and is reported to have offered approximately USD $870 million for a 100% stake, slightly ahead of Sweden’s EQT Partners' bid of $855-860 […]
August 29, 2024

Clariane exits the UK and makes progress on Dutch and Belgium sale

Pan-European listed French nursing home group Clariane has successfully exited the UK with the sale of its Berkley Care subsidiary. The group has also made progress on the sale of its Belgian and Dutch branches, but has not yet secured a buyer for these.
March 8, 2024

KPJ to focus on Malaysia and exit other markets

Listed Malaysian hospital group KPJ Healthcare is selling non-core assets it holds outside of Malaysia to focus on its Malaysian hospital segment. It has already fully exited Indonesia and plans to fully exit Australia within the next two years, and may also exit Bangladesh. It still has a hospital in Thailand which it has no plans to sell, as it is focused on medical tourism - a key part of the company's strategy going forward. The company reported strong results for 2023, with revenue up 19% and core net profit up 61%.
February 23, 2024

Goldman Sachs raises $650m for life sciences

Global investment banking firm Goldman Sachs has closed one of the largest first-time private life sciences growth funds. Its West Street Life Sciences I raised "$650 million in equity commitments from a global, diverse group of institutional, strategic and high net worth investors and meaningful commitment from Goldman Sachs employees" according to the bank.
January 12, 2024

New weight loss drugs to create $100bn+ private health care market

New highly effective weight loss drugs could create a market worth more than $100bn in annual revenue by 2030. Whilst the majority of this value will be captured by the pharma industry, HBI hears there will be a significant role for specialised clinical providers who can deliver these medicines alongside behavioural and lifestyle changes. 
December 15, 2023
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us